[1]
|
Kumar, R. and Nylén, S. (2012) Immunobiology of Visceral Leishmaniasis. Frontiers in Immunology, 3, 251. https://doi.org/10.3389/fimmu.2012.00251
|
[2]
|
Zijlstra, E.E. (2001) Leishmaniasis in Sudan Leishmaniasis. Transactions of the Royal Society of Tropical Medicine and Hygiene, 89, 647-652.
|
[3]
|
Kamil, A.A., Khalil, E.A.G., Musa, A.M., et al. (2003) Alum-Precipitated Autoclaved Leishmania Major plus Bacille Calmette-Guérrin, a Candidate Vaccine for Visceral Leishmaniasis: Safety, Skin-Delayed Type Hypersensitivity Response and Dose Finding in Healthy Volunteers. Transactions of the Royal Society of Tropical Medicine and Hygiene, 97, 365-368. https://doi.org/10.1016/S0035-9203(03)90171-4
|
[4]
|
El Hassan, A.M. and Khalil, E.A. (2001) Post-Kala-Azar Dermal Leishmaniasis: Does It Play a Role in the Transmission of Leishmania donovani in the Sudan? Tropical Medicine & International Health, 6, 743-744. https://doi.org/10.1046/j.1365-3156.2001.00776.x
|
[5]
|
Khalil, E.A.G., Ayed, N.B., Musa, A.M., et al. (2005) Dichotomy of Protective Cellular Immune Responses to Human Visceral Leishmaniasis. Clinical & Experimental Immunology, 140, 349-353. https://doi.org/10.1111/j.1365-2249.2005.02768.x
|
[6]
|
Alvar, J., Vélez, I.D., Bern, C., Herrero, M., Desjeux, P., Cano, J., Jannin, J. and de Boer, M. (2012) Leishmaniasis Worldwide and Global Estimates of Its Incidence. PLoS ONE, 7, e35671. https://doi.org/10.1371/journal.pone.0035671
|
[7]
|
Zijlstra, E.E., El-Hassan, A.M. and Zijlstra, E.E. (1993) Leishmanin and Tuberculin Sensitivity in Leishmaniasis in the Sudan, with Special Reference to Kala-Azar. Transactions of the Royal Society of Tropical Medicine and Hygiene, 87, 425-427. https://doi.org/10.1016/0035-9203(93)90024-K
|
[8]
|
Zijlstra, E.E., Musa, A.M., Khalil, E.A.G., El Hassan, I.M. and El-Hassan, A.M. (2003) Post-Kala-Azar Dermal Leishmaniasis. Lancet Infectious Diseases, 3, 87-98. https://doi.org/10.1016/S1473-3099(03)00517-6
|
[9]
|
Ismail, A., Khalil, E.A.G., Musa, A.M., El Hassan, I.M., Ibrahim, M.E., Theander, T.G. and El Hassan, A.M. (2006) The Pathogenesis of Post Kala-Azar Dermal Leishmaniasis from the Field to the Molecule: Does Ultraviolet Light (UVB) Radiation Play a Role? Medical Hypotheses, 66, 993-999. https://doi.org/10.1016/j.mehy.2005.03.035
|
[10]
|
Ansari, N.A., Kumar, R., Raj, A. and Salotra, P. (2008) Elevated Levels of IgG3 and IgG4 Subclass in Paediatric Cases of Kala Azar. Parasite Immunology, 30, 403-409. https://doi.org/10.1111/j.1365-3024.2008.01036.x
|
[11]
|
Mohamed-Ahmed, A.H.A., Brocchini, S. and Croft, S.L. (2012) Recent Advances in Development of Amphotericin B Formulations for the Treatment of Visceral Leishmaniasis. Current Opinion in Infectious Diseases, 25, 695-702. https://doi.org/10.1097/QCO.0b013e328359eff2
|
[12]
|
Paletta-Silva, R. and Meyer-Fernandes, J.R. (2012) Adenosine and Immune Imbalance in Visceral Leishmaniasis: The Possible Role of Ectonucleotidases. Journal of Tropical Medicine, 2012, Article ID: 650874. https://doi.org/10.1155/2012/650874
|
[13]
|
Faleiro, R.J., Kumar, R., Hafner, L.M. and Engwerda, C.R. (2014) Immune Regulation during Chronic Visceral Leishmaniasis. PLOS Neglected Tropical Diseases, 8, e2914. https://doi.org/10.1371/journal.pntd.0002914
|
[14]
|
Zijlstra, E.E. (2016) The Immunology of Post-Kala-Azar Dermal Leishmaniasis (PKDL). Parasites & Vectors, 9, 464. https://doi.org/10.1186/s13071-016-1721-0
|
[15]
|
Benoist, C. and Mathis, D. (2001) Autoimmunity Provoked by Infection: How Good Is the Case for T Cell Epitope Mimicry? Nature Immunology, 2, 797-801. https://doi.org/10.1038/ni0901-797
|
[16]
|
Wucherpfennig, K.W. (2001) Mechanisms for the Induction of Autoimmunity by Infectious Agents. Journal of Clinical Investigation, 108, 1097-1104. https://doi.org/10.1172/JCI200114235
|
[17]
|
Bussone, G. and Mouthon, L. (2009) Autoimmune Manifestations in Primary Immune Deficiencies. Autoimmunity Reviews, 8, 332-336. https://doi.org/10.1016/j.autrev.2008.11.004
|
[18]
|
Jesus, A.A., Duarte, A.J.S. and Oliveira, J.B. (2008) Autoimmunity in Hyper-IgM Syndrome. Journal of Clinical Immunology, 28, S62-S66. https://doi.org/10.1007/s10875-008-9171-x
|
[19]
|
Meffre, E. and Wardemann, H. (2008) B-Cell Tolerance Checkpoints in Health and Autoimmunity. Current Opinion in Immunology, 20, 632-638. https://doi.org/10.1016/j.coi.2008.09.001
|
[20]
|
Kühne, V. and Büscher, P. (2019) The Unknown Nature of the Antigen in the Direct Agglutination Test for Visceral Leishmaniasis Hampers Development of Serodiagnostic Tests. American Journal of Tropical Medicine and Hygiene, 100, 246-255. https://doi.org/10.4269/ajtmh.18-0740
|
[21]
|
Mukherjee, S., Sengupta, R., Mukhopadhyay, D., Braun, C., Mitra, S., Roy, S., et al. (2019) Impaired Activation of Lesional CD8+ T-Cells Is Associated with Enhanced Expression of Programmed Death-1 in Indian Post Kala-Azar Dermal Leishmaniasis. Scientific Reports, 9, Article No. 762. https://doi.org/10.1038/s41598-019-48640-0
|
[22]
|
Zijlstra, E.E. (2019) Biomarkers in Post-Kala-Azar Dermal Leishmaniasis. Frontiers in Cellular and Infection Microbiology, 9, 228. https://doi.org/10.3389/fcimb.2019.00228
|
[23]
|
Santiago, M., Martinelli, R., Ko, A., Reis, E.A., Fontes, R.D., Nascimento, E.G., et al. (2001) Anti-β2 Glycoprotein I and Anticardiolipin Antibodies in Leptospirosis, Syphilis and Kala-Azar. Clinical and Experimental Rheumatology, 19, 425-430.
|
[24]
|
Schurman, C. (2003) Autoimmunity in Wiskott-Aldrich Syndrome. Current Opinion in Rheumatology, 15, 446-453. https://doi.org/10.1097/00002281-200307000-00012
|
[25]
|
Gambineri, E., Torgerson, T.R. and Ochs, H.D. (2003) Immune Dysregulation, Polyendocrinopathy, Enteropathy, and X. Current Opinion in Rheumatology, 15, 430-435. https://doi.org/10.1097/00002281-200307000-00010
|
[26]
|
Rioux, J.D. and Abbas, A.K. (2005) Paths to Understanding the Genetic Basis of Autoimmune Disease. Nature, 435, 584-589. https://doi.org/10.1038/nature03723
|
[27]
|
Atta, A.M., Carvalho, E.M., Jerônimo, S.M.B. and Sousa Atta, M.L.B. (2007) Serum Markers of Rheumatoid Arthritis in Visceral Leishmaniasis: Rheumatoid Factor and Anti-Cyclic Citrullinated Peptide Antibody. Journal of Autoimmunity, 28, 55-58. https://doi.org/10.1016/j.jaut.2006.12.001
|
[28]
|
Moraes-Vasconcelos, D., Costa-Carvalho, B.T., Torgerson, T.R. and Ochs, H.D. (2008) Primary Immune Deficiency Disorders Presenting as Autoimmune Diseases: IPEX and APECED. Journal of Clinical Immunology, 28, 11-19. https://doi.org/10.1007/s10875-008-9176-5
|
[29]
|
Sakkas, L.I., Boulbou, M., Kyriakou, D., Makri, I., Sinani, C., Germenis, A. and Stathakis, N. (2008) Immunological Features of Visceral Leishmaniasis May Mimic Systemic Lupus Erythematosus. Clinical Biochemistry, 41, 65-68. https://doi.org/10.1016/j.clinbiochem.2007.10.008
|
[30]
|
Chapel, H. and Cunningham-Rundles, C. (2009) Update in Understanding Common Variable Immunodeficiency Disorders (CVIDs) and the Management of Patients with These Conditions. British Journal of Haematology, 145, 709-727. https://doi.org/10.1111/j.1365-2141.2009.07669.x
|
[31]
|
Münz, C., Lünemann, J.D., Getts, M.T. and Miller, S.D. (2009) Antiviral Immune Responses: Triggers of or Triggered by Autoimmunity? Nature Reviews Immunology, 9, 246-258. https://doi.org/10.1038/nri2527
|
[32]
|
Cunningham-Rundles, C. (2001) Autoimmunity in Primary Immune Deficiency: Taking Lessons from Our Patients. Clinical & Experimental Immunology, 164, 6-11. https://doi.org/10.1111/j.1365-2249.2011.04388.x
|
[33]
|
Walker, L.S.K. and Abbas, A.K. (2002) The Enemy Within: Keeping Self-Reactive T Cells at Bay in the Periphery. Nature Reviews Immunology, 2, 11-19. https://doi.org/10.1038/nri701
|
[34]
|
Granel, B., Serratrice, J., Swiader, L., Gambarelli, F., Daniel, L., Fossat, C., et al. (2000) Crossing of Antinuclear Antibodies and Anti-Leishmania Antibodies. Lupus, 9, 548-550. https://doi.org/10.1177/096120330000900713
|
[35]
|
Voulgari, P.V., Pappas, G.A., Liberopoulos, E.N., Elisaf, M., Skopouli, F.N. and Drosos, A.A. (2004) Visceral Leishmaniasis Resembling Systemic Lupus Erythematosus. Annals of the Rheumatic Diseases, 63, 1348-1349. https://doi.org/10.1136/ard.2003.014480
|
[36]
|
Erduran, E., Bahadir, A. and Gedik, Y. (2005) Kala-Azar Associated with Coombs-Positive Autoimmune Hemolytic Anemia in the Patients Coming from the Endemic Area of This Disease and Successful Treatment of These Patients with Liposomal Amphotericin B. Pediatric Hematology and Oncology, 22, 349-355. https://doi.org/10.1080/08880010590964110
|
[37]
|
Dalgiç, B., Dursun, I. and Akyol, G. (2005) A Case of Visceral Leishmaniasis Misdiagnosed as Autoimmune Hepatitis. Turkish Journal of Gastroenterology, 16, 52-53.
|
[38]
|
Makaritsis, K.P., Gatselis, N.K., Ioannou, M., Petinaki, E. and Dalekos, G.N. (2009) Polyclonal Hypergammaglobulinemia and High Smooth-Muscle Autoantibody Titers with Specificity against Filamentous Actin: Consider Visceral Leishmaniasis, Not Just Autoimmune Hepatitis. International Journal of Infectious Diseases, 13, e157-e160. https://doi.org/10.1016/j.ijid.2008.08.011
|
[39]
|
Werneck, G.L., Batista, M.S.A., Gomes, J.R.B., Costa, D.L. and Costa, C.H.N. (2003) Prognostic Factors for Death from Visceral Leishmaniasis in Teresina, Brazil. Infect, 31, 174-177. https://doi.org/10.1007/s15010-003-3139-9
|
[40]
|
Madalosso, G., Fortaleza, C.M., Ribeiro, A.F., Cruz, L.L., Nogueira, P.A. and Lindoso, J.A.L. (2012) American Visceral Leishmaniasis: Factors Associated with Lethality in the State of São Paulo, Brazil. Journal of Tropical Medicine, 2012, Article ID: 281572. https://doi.org/10.1155/2012/281572
|